Tributes paid to IRD founder Art Bergan - ITS International
2 weeks ago • Google News
Opus Genetics, Inc. (IRD)
US$ 1.115.71%
Price Chart
Key Statistics
Market Cap
$ 35.67M
P/E Ratio
0.00
Revenue (TTM)
$ 8.38M
Volume
153.66K
52W High
$ 2.18
52W Low
$ 0.65
Dividend Yield
0.00%
Beta
0.24
Technicals
50-Day MA
1.1492
200-Day MA
1.3971
52 Week High
2.18
52 Week Low
0.65
About IRD
Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs).
Employees
18
Headquarters
Durham, NC
CEO
Mr. George Magrath M.B.A., M.D., M.S.
Latest News
My Internship Experience at the IRD - Juicy Ecumenism
2025-04-03 • Google News
New collaboration agreement signed by SEI and IRD - Stockholm Environment Institute
2024-12-06 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg